Reduced Long Term Indebtedness Through Partial Prepayment Strengthened Product Portfolio and Wholesale Growth TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2025. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary “Our fourth quarter reflected continued progress on our strategic priorities, with a strong focus on cost optimization and simplifying our operations. In Florida, our Rosa cultivation facility delivered increased output and improved quality, helping to rebalance production across our cultivation footprint. We anticipate...

RESULTS AT 31 MARCH 2026Press release                                                         Paris, 30 April 2026 at 6:25 a.m. ROTE OF 11.7%1 IN Q1 26, WELL ABOVE THE 2026 TARGET COST-TO-INCOME RATIO OF 60.9%2 IN Q1 26 COSTS DOWN -6.0% VS. Q1 25 COST OF RISK OF 25BPS, AT THE LOW END OF THE 2026 GUIDANCE RANGERevenues of EUR 7.1 billon in Q1 26, up by +0.3% vs. Q1 25 Strict cost discipline with operating expenses down -6.0% vs. Q1 25, better than the 2026 annual target of a decrease of ~-3% Cost-to-income ratio of 60.9%2 in Q1 26 vs. 65.0% in Q1 25 Cost of risk at 25bps in Q1 26, at the low end of the 2026 guidance range of 25 to 30bps. High S1/S2 buffer of EUR 2.9bn (or ~2.0x 2025 cost of risk) Group net income of EUR 1,696 million in Q1 26, +5.5% vs. Q1 25 Profitability (ROTE) of 11.7% and 12.7% with IFRIC 21 linearisation and excluding...

SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) — California Water Service Group (Group or Company, NYSE: CWT), a leading publicly traded water utility serving California, Hawaii, New Mexico, Washington, and Texas, today reported first quarter 2026 results and provided an update on the revised proposed decision issued by the California Public Utilities Commission (CPUC) on April 29, 2026 (revised PD) on California Water Service Company’s (Cal Water’s) 2024 California General Rate Case (2024 CA GRC). First Quarter 2026 in Line with Expectations Given Pending Decision on 2024 CA GRC The Company reported that first-quarter 2026 results were in line with expectations as the Company awaits a final decision on the 2024 CA GRC, which is expected on April 30, 2026, or shortly thereafter. Once a final decision is adopted, the Company has...

CALGARY, Alberta, April 29, 2026 (GLOBE NEWSWIRE) — This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. This news release contains references to certain Financial Measures and Ratios, including Adjusted EBITDA (earnings before income taxes, (gain) loss on investments and other assets, finance charges, foreign exchange, gain on asset disposals and depreciation and amortization), Net Capital Spending, Working Capital and Total Long-Term Financial Liabilities. These terms do not have standardized meanings prescribed under International Financial...

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third fiscal quarter ended March 31, 2026. “We’ve had a busy and exciting March quarter marked by a series of major achievements. Ryoncil® revenues are now approaching US$100 million since last year’s launch, we have substantially improved our net operating cash spend, our pivotal trial in inflammatory back pain has successfully achieved its patient recruitment target, and we have bolstered our long-term leadership in the field by acquiring genetically modified technology...

Fourth quarter 2025 revenue up 75% compared to the fourth quarter 2024 Fourth quarter 2025 gross profit increased 78% compared to the fourth quarter 2025 Fourth quarter same-store sales up 6% and same-store prescription sales up 3.8 %, supplementary financial measures, both compared to fourth quarter 2025SASKATOON, Saskatchewan, April 29, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today reported its financial results for fourth quarter and year ended December 31, 2025. “Our financial results reflect our steady progress in scaling the business through disciplined M&A, the successful integration of recently acquired stores, and the operational excellence of our pharmacies,”...

This news release contains forward-looking information about expected future events that is subject to risks and assumptions set out in the “Cautionary Statement on Forward-Looking Information” below. All figures are in United States dollars. All production figures reflect payable metal quantities and are on a 100% basis, unless otherwise stated. For references denoted with NG, refer to the “Non-GAAP and Other Financial Measures” disclosure at the end of this news release for a description of these measures. TORONTO, April 29, 2026 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG and NYSE: CGAU) today reported its first quarter 2026 operating and financial results. President and CEO, Paul Tomory, commented, “Centerra delivered a strong start to the year, with production performing in line with plan across...

VANCOUVER, British Columbia, April 29, 2026 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its audited results for the financial year ended December 31, 2025 (“YE 2025”). The audited, consolidated financial statements at year-end 2025, together with the related management’s discussion and analysis, are available on the Company’s website and under the Company’s profile at www.sedarplus.ca. HighlightsCommenced leaching at the Calcatreu project on March 31, 2026, the Company’s flagship project in Rio Negro. Generated revenue of US$9 million in 2025. Produced 2,172 gold equivalent ounces and sold 2,678 gold equivalent ounces (1). Spent approximately US$2 million on the Company’s projects in Santa Cruz and Rio Negro.Notes:(1)   Consisting of 1,265 gold and 80,798 silver ounces of production...

Except where otherwise noted, all currency amounts are stated in United States dollars. Financial and Production HighlightsNet loss attributable to Methanex shareholders of $14 million, which is primarily driven by the increase in our share price and the resulting mark-to-market expense of share-based compensation in the first quarter, Adjusted EBITDA of $220 million, and Adjusted net income of $23 million. Our average realized price in the first quarter was $351 per tonne compared to $331 per tonne in the fourth quarter of 2025. Based on our April and May posted prices, we expect that our average realized price range will be approximately $500 to $525 per tonne for these two months. Produced 2,391,000 tonnes of methanol in the first quarter compared to 2,364,000 tonnes in the fourth quarter of 2025. Repaid $60 million of the Term Loan...

Delivered record free cash flow for the 4th consecutive quarter, margins continued to outpace gold priceReturned approximately $350 million to shareholders to date in 2026, $1 billion since Q1 2025Significant progress across pipeline of development projects TORONTO, April 29, 2026 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K, NYSE: KGC) (“Kinross” or the “Company”) today announced its results for the first quarter ended March 31, 2026.This news release contains forward-looking information about expected future events and financial and operating performance of the Company. We refer to the risks and assumptions set out in our Cautionary Statement on Forward-Looking Information located on pages 24 and 25 of this release. All dollar amounts are expressed in U.S. dollars, unless otherwise noted. 2026 first-quarter highlights:Production1...